Uveitis Clinical Trials

Find Uveitis Clinical Trials Near You

Influência de imunomodulação Precoce Influence of Early Immunosuppressive Therapy on the Course of Vogt-Koyanagi-Harada Disease: a Prospective Study

Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This prospective study will include patients with Vogt-Koyanagi-Harada disease from disease onset, treated with early systemic high-dose corticosteroid and immunosuppressive therapy. Clinical and subclinical signs of disease activity added with electroretinogram exams, through predefined intervals, will be evaluated through a minimum 12-month follow-up.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 10
Maximum Age: 70
Healthy Volunteers: f
View:

• \- acute Vogt-Koyanagi-Harada disease

Locations
Other Locations
Brazil
Hospital das Clinicas HCFMUSP, Faculdade de Medicina Universidade de Sao Paulo
RECRUITING
São Paulo
Contact Information
Primary
Joyce H Yamamoto, MD
joycehy@uol.com.br
55-11-99266-6474
Time Frame
Start Date: 2015-03-23
Estimated Completion Date: 2028-12
Participants
Target number of participants: 40
Treatments
Other: Treatment group
Early high-dose corticosteroid and immunosuppressive therapy
Related Therapeutic Areas
Sponsors
Collaborators: Fundação de Amparo à Pesquisa do Estado de São Paulo
Leads: University of Sao Paulo

This content was sourced from clinicaltrials.gov

Similar Clinical Trials